These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1424420)

  • 1. Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
    Sahai J; Gallicano K; Garber G; Pakuts A; Hawley-Foss N; Huang L; McGilveray I; Cameron DW
    Clin Pharmacol Ther; 1992 Nov; 52(5):464-70. PubMed ID: 1424420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
    Sahai J; Gallicano K; Pakuts A; Cameron DW
    J Infect Dis; 1994 May; 169(5):1103-7. PubMed ID: 8169401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.
    Sahai J; Gallicano K; Garber G; Pakuts A; Cameron W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):54-60. PubMed ID: 7648285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of indomethacin and naproxen on zidovudine pharmacokinetics.
    Barry M; Howe J; Back D; Breckenridge A; Brettle R; Mitchell R; Beeching NJ; Nye FJ
    Br J Clin Pharmacol; 1993 Jul; 36(1):82-5. PubMed ID: 8373716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
    Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients.
    Van Harken DR; Pei JC; Wagner J; Pike IM
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2480-3. PubMed ID: 9371353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients.
    Gallicano KD; Sahai J; Shukla VK; Seguin I; Pakuts A; Kwok D; Foster BC; Cameron DW
    Br J Clin Pharmacol; 1999 Aug; 48(2):168-79. PubMed ID: 10417493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rifabutin on the pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus.
    Gallicano K; Sahai J; Swick L; Seguin I; Pakuts A; Cameron DW
    Clin Infect Dis; 1995 Oct; 21(4):1008-11. PubMed ID: 8645788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine.
    Lee BL; Täuber MG; Sadler B; Goldstein D; Chambers HF
    Clin Pharmacol Ther; 1996 Jan; 59(1):14-21. PubMed ID: 8549029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.
    Tartaglione TA; Collier AC; Opheim K; Gianola FG; Benedetti J; Corey L
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2225-31. PubMed ID: 1803995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patients.
    Gallicano K; Sahai J; Ormsby E; Cameron DW; Pakuts A; McGilveray I
    Br J Clin Pharmacol; 1993 Aug; 36(2):128-31. PubMed ID: 8398581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patients.
    Sahai J; Gallicano K; Ormsby E; Garber G; Cameron DW
    AIDS; 1994 Jun; 8(6):793-6. PubMed ID: 8086138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection.
    Lee BL; Safrin S; Makrides V; Gambertoglio JG
    Antimicrob Agents Chemother; 1996 May; 40(5):1231-6. PubMed ID: 8723472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patients.
    Sahai J; Gallicano K; Garber G; McGilveray I; Hawley-Foss N; Turgeon N; Cameron DW
    Br J Clin Pharmacol; 1992 Jun; 33(6):657-60. PubMed ID: 1389940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus.
    Lertora JJ; Rege AB; Greenspan DL; Akula S; George WJ; Hyslop NE; Agrawal KC
    Clin Pharmacol Ther; 1994 Sep; 56(3):272-8. PubMed ID: 7924122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of zidovudine phosphorylation in patients infected with the human immunodeficiency virus.
    Stretcher BN; Pesce AJ; Hurtubise PE; Frame PT
    Ther Drug Monit; 1992 Aug; 14(4):281-5. PubMed ID: 1519301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients.
    Morse GD; Portmore AC; Marder V; Plank C; Olson J; Taylor C; Bonnez W; Reichman RC
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2245-52. PubMed ID: 1444306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of high-dose zidovudine administered as a continuous infusion in patients with cancer.
    Marchbanks K; Dudley MN; Posner MR; Darnowski J
    Pharmacotherapy; 1995; 15(4):451-7. PubMed ID: 7479197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection.
    Schwartz EL; Brechbühl AB; Kahl P; Miller MA; Selwyn PA; Friedland GH
    J Acquir Immune Defic Syndr (1988); 1992; 5(6):619-26. PubMed ID: 1588496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine pharmacokinetics in HIV-positive women during different phases of the menstrual cycle.
    Cordaro JA; Morse GD; Bartos L; Gugino LJ; Maliszewski M; Colomaio R; Shelton M; O'Donnell A; Hewitt R
    Pharmacotherapy; 1993; 13(4):369-77. PubMed ID: 8361863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.